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Introduction
Hormone replacement therapy is one of the most
commonly prescribed medications for menopausal
women. Estrogen replacement therapy can decrease the
risk of developing numerous disorders, including osteo-
porosis, hot flashes and Alzheimer’s disease. Artificial
synthetic estrogen, the current and most effective agent
for hormone replacement therapy, is widely used. How-
ever, fears of side effects from estrogen therapy have
motivated many patients to seek alternative modalities
for symptomatic relief. Requests for complementary/
alternative therapies for hormone replacement have
thus dramatically increased. A currently popular alterna-
tive treatment is wild yam (Dioscorea villosa). Wild yam
or diosgenin (extracted from the root of wild yam) has
been applied in hormone replacement therapy [1].
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SUMMARY
Objective: Yam or diosgenin (extracted from the root of wild yam) is traditionally used for hormone replacement
in menopausal women. Calpains are crucially related to the degradation of myofibrillar proteins in skeletal
muscle. This study aimed to investigate the effects of yam and diosgenin on the calpain isoform expression in
ovariectomized rats, a model of menopausal status.
Materials and Methods: Female rats were divided into: (1) controls; (2) ovariectomized rats; (3) ovariectomized
rats receiving yam (250, 750, 1,500 mg/kg/day); (4) ovariectomized rats receiving diosgenin (10, 50, 100 mg/kg/
day). Yam and diosgenin were administered for 8 weeks. The expression of µ- and m-calpain in skeletal muscles
was determined by reverse transcriptase-polymerase chain reaction.
Results: The µ-calpain/β-actin and m-calpain/β-actin ratios in the control group (0.9 and 1.09, respectively)
were significantly higher than those in the ovariectomized group (0.58 and 0.72, respectively). In the yam group,
the expression of µ- and m-calpain was lowest in the ovariectomized group receiving no supplementation and
lower in the 250 mg group compared with the 750 and 1,500 mg groups (for 0, 250, 750 and 1,500 mg dosage
groups, µ-calpain, 0.58, 0.88, 1.24 and 1.13, respectively; m-calpain, 0.72, 1.02, 1.38 and 1.47, respectively).
In contrast, there were no significant differences in the expression of µ- and m-calpain mRNAs among the dif-
ferent diosgenin dosage groups (for 0, 10, 50 and 100 mg of diosgenin, µ-calpain, 0.58, 0.56, 0.62 and 0.58,
respectively; m-calpain, 0.72, 0.58, 0.71 and 0.54, respectively). Decreased expression of µ- or m-calpain was
observed in the ovariectomized group compared with the normal controls.
Conclusion: Yam, but not its extract (diosgenin), is associated with the regulation of calpain isoforms in ovariec-
tomized rats. Adequate yam supplements might improve the muscular calpain-related physiopathology associated
with menopausal status. [Taiwan J Obstet Gynecol 2008;47(2):180–186]
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Wild yam and its extracts have been used to mini-
mize postmenopausal symptoms. At present, many
menopausal women take traditional herbal medicines,
such as yam or diosgenin, to substitute for the female
hormone (estrogen). Yam contains steroidal saponins,
which can influence endogenous steroidogenesis [2].
Diosgenin, a type of steroidal saponin, is synthetically
derived from the root of wild yam using an analytical
separation assay procedure. Diosgenin can be converted
into human progesterone, aldosterone, cortisol and
estrogen through a series of enzymatic steps [3]. How-
ever, the effect of wild yam or diosgenin on menopausal
women remains obscure, as information about the
efficacy and safety of natural medicine on menopausal
women is still lacking.
The calcium-dependent proteinase (calpain) system
is found in every vertebrate cell; contraction of the
skeletal muscle is associated with the calcium-dependent
protease calpain system [4,5]. Calpains are calcium-
modulated proteases which respond to calcium (Ca2+)
signals by removing limited portions of protein sub-
strates, thereby irreversibly modifying their functions.
Calpain is a cytoplasmic cysteine protease activated by
calcium ions [6]. There are several major ubiquitous
calpain isoforms, including µ-calpain and m-calpain.
Both µ-calpain and m-calpain require micromolar and
millimolar calcium concentrations for activation [6,7].
The µ-calpain is accompanied by limited autoproteolysis;
m-calpain can be activated by µ-calpain [8]. Although
the physiologic function of calpain isoforms remains
obscure, they take part in a variety of calcium-regulated
cellular processes such as signal transduction, cell pro-
liferation, cell cycle progression, differentiation, apop-
tosis, membrane fusion, and platelet activation [9–12].
Estrogen and estrogen receptors (ERs) can influence
the expression of calpain isoforms in menopausal women
[13]. Estrogen influences the development and function
of the nervous system through ER-dependent changes
in gene expression and by rapidly influencing diverse
intracellular signaling pathways [14]. Calpain expres-
sion in the pituitary gland may be upregulated by estro-
gen at the transcription level [15]. Estrogen influences
the calpain isoform activities in skeletal and cardiac
muscles [16]. In reviewing the MEDLINE database, we
found that no investigators have demonstrated the
effect of yam or diosgenin administration on the cal-
pain presentation of skeletal muscle in ovariectomized
rats or menopausal women. The objective of this study
was to determine whether the addition of yam or dios-
genin modulates the calpain isoform (µ-calpain, m-
calpain) expression in ovariectomized rats. To the best
of our knowledge, this is the first such study in the
aspect of yam or diosgenin.
Materials and Methods
Animals
Seven-week-old female Sprague-Dawley rats (n = 56;
birth weight, 300–350 g) were divided into four groups:
(1) control rats (n = 7); (2) ovariectomized rats (n = 7);
(3) ovariectomized rats receiving yam (250, 750,
1,500 mg/kg/day; total, n = 21; individual dosage group,
n = 7); (4) ovariectomized rats receiving diosgenin,
which is extracted from the root of wild yam (10, 50,
100 mg/kg/day; total, n = 21; each subgroup, n = 7).
Wild Chinese yam (obtained from a traditional herb
market) or diosgenin (Sigma Chemical Co., St Louis,
MO, USA) was administered to ovariectomized rats
for 8 weeks. All groups of rats were of the same age.
The ambient temperature was maintained between
22°C–24°C and the animals were kept under an artificial
12-hour light–dark cycle. The rats were provided with
standard laboratory chow and water ad libitum. All pro-
tocols were approved by the Institutional Animal Care
and Use Committee of China Medical University and
Chang Shan Medical University in Taichung, Taiwan.
RNA extraction and reverse transcription reaction
All rats were sacrificed after 8 weeks of feeding. Tissues
were removed immediately and washed with cold phos-
phate buffer. The tissue was cut into portions and stored
separately at –70°C for later analysis. The expression
of calpain isoforms (µ-calpain, m-calpain) in skeletal
muscles was determined by reverse transcriptase-
polymerase chain reaction using β-actin as an internal
standard. Total RNA was extracted from the rat skeletal
muscles using Trizol (Invitrogen Corp., Carlsbad, CA,
USA). One microgram of each total RNA was reverse-
transcribed into cDNA with the RNA polymerase chain
reaction (PCR) kit (Invitrogen Corp., Carlsbad, CA,
USA) using oligo (dT) primer. The reaction was carried
out at 50°C for 60 minutes. The reverse transcriptase
was inactivated by incubation at 98°C for 5 minutes
and kept at 4°C.
PCR conditions
The reverse transcription reaction products were mea-
sured by PCR analysis, using mRNA-encoding rat β-actin
as an internal standard. All PCR reactions were per-
formed as follows: 1 µL of cDNA was used for amplifi-
cation with 1U of Taq DNA polymerase (Qiagen, Hilden,
Germany), 5 µL of PCR buffer, 5 µL of each 10 mM
dNTPs, and 1 pmol of each specific upstream and down-
stream primers. The individual primer sequences were
designed as follows: µ-calpain, 5-GGTCAGCCTGTGC-
ACTTGAAGCG and 3-TTGTGGGGCTCGAAGGTGGA-
GGG; m-calpain, 5-CACAACCCGAGCCAGGGAGCG
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and 3-TTGTGGGGCTCGAAGGTGGAGGG; and cal-
pain 10, 5-AACCCAGCGAGGTGTGTGTGGCTGTT
and 3-GCAGTGTTGCTGTAGGGTGATACGGATG. PCR
amplification was performed under the following con-
ditions: 94°C for 5 minutes, then 30 cycles at 94°C for
1 minute, 55°C for 1 minute and 72°C for 1 minute,
with a final elongation at 72°C for 7 minutes. The PCR
products were analyzed by electrophoresis in 2% agarose
gel containing 0.5 µg/mL ethidium bromide.
Preparation of tissue and cell extracts for 
Western blotting
Rat skeletal muscles were homogenized in ice-cold buffer
B (20 mM Tris-HCl [pH 7.5], 0.25 M sucrose, 50 mM
β-mercaptoethanol, 1 mM phenylmethylsulfonyl fluo-
ride, 200µg/mL of leupeptin, 5mM EDTA, 2mM EGTA,
10 mM benzamidine) using a homogenizer. Tissues
were centrifuged at 100,000 × g for 30 minutes at 4°C.
Supernatants were used as the cytosolic fraction. To
obtain membrane fractions, the pellets were washed
and extracted with buffer B containing 1% Triton X-100.
After a 30-minute incubation at 4°C, the samples were
centrifuged at 100,000 × g for 30 minutes, yielding the
solubilized membrane fraction. Protein concentrations
of individual samples were determined by the Bradford
method [17].
Western blot analyses of m-calpain and 
m-calpain
Effects of ovariectomization and yam and diosgenin
administration upon the m- and µ-calpain in skeletal
muscle of female Sprague-Dawley rats were deter-
mined by Western blot analysis. Protein samples were
subjected to 10% sodium dodecyl-polyacrylamide gel
electrophoresis according to the Laemmli method [18].
The separated proteins were electrophoretically trans-
ferred to a 0.22 µm nitrocellulose membrane (Hybond-
C Super or Hybond-ECL; Amersham Life Science,
Buckinghamshire, UK) at 4°C overnight using a Bio-
Rad transfer blot apparatus (30 mA; Bio-Rad, CA, USA).
Nonspecific sites were blocked with 5% skim milk in
TTBS (50 mM Tris-HCl [pH 7.5], 0.15 M NaCl, 0.05%
Tween-20) for 1 hour at room temperature. The mem-
branes were incubated for 2 hours at room temperature
and were sequentially diluted to 1:2,500 with anti-rabbit
µ- or m-calpain. The membranes were washed and incu-
bated for 1 hour with a 1:2,000 dilution of secondary
(alkaline phosphatase-conjugated goat anti-rabbit IgG).
After three washings, antibody-reactive bands were visu-
alized by an enhanced chemiluminescence detection
system (Amersham Life Science, Buckinghamshire, UK).
The blots were scanned using a GeneGnome bio imaging
system (Syngene, Frederick, MD, USA).
Statistical analysis
All data are presented as mean ± standard deviation.
SAS version 8.1 software (SAS Institute Inc., Cary, NC,
USA) with unpaired Student’s t test was utilized for statis-
tical analysis. A p value of less than 0.05 was considered
statistically significant.
Results
We observed that menopause status (ovariectomiza-
tion) was related to decreased expression of calpain
isoforms. The µ- and m-calpain/β-actin ratios in the
control group were significantly higher than those in
the ovariectomized groups. The expressions of µ-calpain
in the control and ovariectomized groups were 0.9±0.13
and 0.58 ± 0.11, respectively (p < 0.05; Figure 1A). The
expressions of m-calpain in the control and ovariec-
tomized groups were 1.09 ± 0.1 and 0.72 ± 0.08,
respectively (p < 0.05; Figure 1B).
In ovariectomized rats receiving the yam, administra-
tion of high doses of yam appeared to increase the ex-
pression of calpain isoforms. The expressions of µ- and
m-calpain were lowest in the ovariectomized group re-
ceiving no yam supplementation, and lower in the group
receiving 250 mg, compared with those receiving 750
and 1,500 mg. The levels of µ-calpain in the 0, 250, 750,
1,500 mg yam groups were 0.58 ± 0.11, 0.88 ± 0.11,
1.24 ± 0.41, 1.13 ± 0.28, respectively (p < 0.05; Figure
2A). The levels of m-calpain in the 0, 250, 750, 1,500 mg
yam groups were 0.72 ± 0.08, 1.02 ± 0.12, 1.38 ± 0.37,
1.47 ± 0.21, respectively (p < 0.05; Figure 2B).
In contrast, the administration of yam extract
(diosgenin) did not seem to influence the expression
of calpain isoforms in ovariectomized rats. There were
no significant differences in the expressions of µ- and
m-calpains among the different diosgenin dosage
groups. The levels of µ-calpain in the 0, 10, 50, and
100 mg diosgenin groups were 0.58 ± 0.11, 0.56 ± 0.08,
0.62 ± 0.14, 0.58 ± 0.25, respectively (Figure 3A). The
levels of m-calpains in 0, 10, 50, and 100 mg diosgenin
groups were 0.72 ± 0.08, 0.58 ± 0.16, 0.71 ± 0.22,
0.54 ± 0.18, respectively (Figure 3B).
Discussion
Artificial estrogen remains the most effective agent for
hormone replacement therapy and prevention of meno-
pausal symptoms, hot flashes and osteoporosis, and
for decreasing the risk of colorectal cancer. However,
estrogen supplement may increase the risk of some
disorders or diseases including breast cancer, heart
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disease, stroke, and pulmonary embolism, which com-
promise its popular application [19]. Over the past
decade, people have been seeking natural alternatives to
treat menopausal symptoms. Currently, some herbal
medicines such as wild yam or its extract have been
widely used to minimize postmenopausal symptoms.
Chinese yam (Dioscorea), a staple food in several trop-
ical countries, is a good source of steroid used in the
manufacture of birth control pills and other sex hormone
preparations [20]. Yam is a common raw material
used for drug and health food manufacture. Wild yam
has been used for women with hot flashes as well as
many other menopausal conditions [21]. Administering
yam improves the status of sex hormones, lipids and
antioxidants in postmenopausal women. [22]. Wild yam
preparations contain diosgenin which can be converted
into progesterone [2,21].
Diosgenin, a biologically active compound of yam,
has tremendous medical applications. Compared with
wild yam, diosgenin appears to be free of some adverse
effects. Diosgenin administration in ovariectomized rats
resulted in increased adrenal tissues, whereas these areas
decreased in diosgenin-treated animals [1,3]. Diosgenin
administration might protect the kidney from mor-
phologic changes associated with ovariectomy [3]. These
findings suggest that diosgenin affects endocrine func-
tion. However, there are insufficient data about these
herbal alternative therapies for menopausal women.
The calpain system, a family of calcium-dependent
cysteine proteases, has been studied for decades [23].
Calpains represent a superfamily of Ca2+-activated
cysteine proteases, which are important mediators of
apoptosis and necrosis. These calpain isoforms might
act independently through different proteasome path-
ways and cleave a number of cellular substrates, includ-
ing kinases, phosphatases, transcription factors and
cytoskeletal proteins [24]. Calpain activity has been
associated with cleavages that alter regulation of various
enzyme activities, remodeling or disassembly of the cell
cytoskeleton, and cleavages of hormone receptors [9].
Calpains are involved in a variety of physiologic and
pathologic disorders [25]. Alterations in calpain iso-
form activity might be related to a number of disorders,
including stroke, traumatic brain injury, Alzheimer’s
disease, cataract, limb-girdle muscular dystrophy and
gastric cancer [26,27].
The calpain system comprises three molecules: 
µ-calpain, m-calpain, and calpastatin [28]. The function
of calpastatin is to inhibit µ-calpain and m-calpain.
Both µ- and m-calpain are heterodimers containing 
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a 30-kDa small subunit and an 80-kDa large subunit
[29]. However, the mechanism regulation of activity of
the calpain system in vivo is unknown. At the cell mem-
brane, calpain is activated in the presence of Ca2+ and
phospholipids. Suzuki and Ohno [29] indicated that
calpain exists in the cytosol as an inactive enzyme and
translocates to membranes in response to increases in
the cellular Ca2+ level. Calpains usually exist in an inactive
form and are activated by calcium and phospholipids
[25,30].
Calpain activity may be regulated by binding Ca2+
to specific sites on the calpain molecule, with binding
to each site eliciting a response (e.g. proteolytic activity,
calpastatin binding) specific for that site. The binding
of the calpains to phospholipid in a cell membrane
might lower the Ca2+ concentration, which is required
for the autolysis of calpains. Furthermore, the autolysis
of calpains converts an inactive proenzyme into an active
protease [9]. The calcium-dependent protease calpain
causes endothelial dysfunction and vascular inflamma-
tion in the microcirculation of the rat [31]. Inhibition
of calpain activity in skeletal muscle is related to equi-
librium in muscle metabolism [32].
Estrogen and ER can exert protective activity in
menopausal women by influencing the expression of
calpains and their endogenous inhibitor, calpastatin
[13]. Estrogen supplements could, therefore, influence
the amount and size of muscle fiber [33]. Hormone
deficiency status in ovariectomized rats might result in
reduced amount of myosin heavy chain [34]. Further-
more, the reduced myosin heavy chain expression could
be reversed with estrogen supplements, which suggests
the estrogen-dependent nature of muscle fibers. Estrogen
might counteract the calpain isoform, which further
influences muscle function in the menopausal women.
Estrogen supplementation in ovariectomized rats also
influences cardiac calpain activity [16,33].
In contrast, calpain plays an important role in the
feedback regulation of estrogen activity and ER function
[35,36]. Calpain might intervene in estrogen activity by
diminishing irreversibly the amount of cytoplasmic ER
capable of translocating into the nucleus [37]. Calpain
has been reported to hydrolyze the ERs [35]. Calpain is
associated with the regulation of ER function as well as
malignant transformation in breast cancer tissues [36].
In this study, we observed decreased levels of µ- or
m-calpain mRNA in ovariectomized rats compared with
normal controls. Ovarian hormone might be related 
to expression of calpain isoforms. Administration of
large dosages of yam increased the expression of both
µ- and m-calpain mRNAs in the skeletal muscle of
ovariectomized rats. Adequate dosages of yam supple-
ment might compensate for the deficiency of ovarian
hormone as well as influence and regulate the calpain
isoform-related pathways in skeletal muscle. These find-
ings suggest the potential of yam administration in
improving the physiopathology of muscle in ovariec-
tomized or menopausal women. Ovarian hormone or
yam administration plays a role in increasing calpain
expression or decreasing calpain degradation, which
are associated with muscle function in menopausal
women. These findings are in agreement with previous
studies, which revealed that estrogen administration
improves menopause-related sequences.
In contrast, some have reported insignificant im-
provement in menopausal symptoms after short-term
administration of topical wild yam extract [2]. We also
found that diosgenin administration had no significant
effect on calpain isoform expression. This research re-
ported on the muscular regulation efficiency of yam
compared with wild yam extract (diosgenin). The results
suggest that the extraction and separation procedure
results in the loss of some related compounds that are
essential for calpain isoform regulation. The information
is important, because compromised calpain isoform
activity might pose potential muscular dysfunction in
menopausal females. However, the underlying mecha-
nisms and physiologic consequences of this activity are
yet to be determined.
In conclusion, ovarian hormone or yam administra-
tion appears to importantly determine the expression
of calpain isoforms. Yam but not its extract (diosgenin)
can regulate calpain isoforms in ovariectomized rats.
The results suggest that yam supplements might improve
the muscular and calpain-related physiopathology of
menopausal status. The efficacy of yam administration
is dose-dependent. This research has highlighted the
correlation between yam or diosgenin supplements and
calpain expression in menopause. However, the under-
lying mechanism and related issues merit further study.
Recruitment of larger cohorts for human survey may
be required for further clarification. Although the real
role of calpain isoforms has not been clarified, it deserves
more attention in terms of the related molecular
mechanisms. After the resolution of these issues, yam
supplementation might become an alternative consid-
eration for the menopausal population.
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